XML 33 R22.htm IDEA: XBRL DOCUMENT v3.23.1
Share-Based Compensation (Tables)
3 Months Ended
Mar. 31, 2023
Share-Based Payment Arrangement [Abstract]  
Schedule of Outstanding Stock Options

Total outstanding stock options as of March 31, 2023 was as follows:

 

 

 

2023

 

 

 

Number of
shares

 

 

Weighted
average
exercise price

 

Outstanding at beginning of period

 

 

8,032,902

 

 

$

14.38

 

Granted

 

 

1,569,640

 

 

$

12.30

 

Exercised

 

 

(2,000

)

 

$

2.24

 

Cancelled or forfeited

 

 

(27,713

)

 

$

18.92

 

Outstanding at end of period

 

 

9,572,829

 

 

$

14.03

 

Schedule of Fair Value of Stock Options Determined on Grant Date Using Black Scholes Option-Pricing Model

The fair value of stock options, and the assumptions used in the Black Scholes option-pricing model to determine the grant date fair value of stock options granted to employees and non-employees were as follows, presented on a weighted average basis:

 

 

Three Months Ended
March 31,

 

 

 

2023

 

 

2022

 

 

 

 

 

 

 

 

Fair value of stock options

 

$

8.85

 

 

$

10.17

 

Risk-free interest rate

 

 

3.65

%

 

 

1.73

%

Expected terms (in years)

 

 

6.08

 

 

 

6.08

 

Expected volatility

 

 

81.77

%

 

 

78.47

%

Expected dividend yield

 

 

0.00

%

 

 

0.00

%

Summary of Total Outstanding Restricted Stock Units

Total outstanding restricted share units as of March 31, 2023 was as follows:

 

 

2023

 

 

 

Number of
shares

 

 

Weighted
average
grant date fair value

 

Outstanding at beginning of period

 

 

 

 

 

 

Awarded

 

 

626,260

 

 

$

12.42

 

Forfeited

 

 

(3,425

)

 

$

12.42

 

Outstanding at end of period

 

 

622,835

 

 

$

12.42

 

The fair value of each restricted share unit is estimated on the date of grant based on the fair value of our common shares on that same date.

Schedule of Share-based Compensation Expense

Share-based compensation expense was allocated as follows:

 

 

Three Months Ended
March 31,

 

 

 

2023

 

 

2022

 

 

 

(in thousands)

 

Research and development

 

$

3,219

 

 

$

2,311

 

General and administrative

 

 

2,843

 

 

 

2,444

 

Total share-based compensation expense

 

$

6,062

 

 

$

4,755

 

Share-based compensation expense by type of award was as follows:

 

 

Three Months Ended
March 31,

 

 

 

2023

 

 

2022

 

 

 

(in thousands)

 

Stock options

 

$

5,537

 

 

$

4,712

 

Restricted share units

 

 

425

 

 

 

 

ESPP

 

 

100

 

 

 

43

 

Total share-based compensation expense

 

$

6,062

 

 

$

4,755